HOXD9 and hepatocellular carcinoma: Our study indicated that HOXD9 and 10 were overexpressed in HCC patients with MVI compared with patients without MVI, and patients with MVI with HOXD9 and 10 overexpression had poorer prognosis than patients with MVI with low expression of HOXD9 and 10.